Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

(2014) Yu Nakamura et al.   EXPERT OPINION ON PHARMACOTHERAPY

Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine

(2013) Mercè Boada et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Effects of Memantine on Clinical Ratings, Fluorodeoxyglucose Positron Emission Tomography Measurements, and Cerebrospinal Fluid Assays in Patients With Moderate to Severe Alzheimer Dementia

(2013) Tao Wang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials

(2013) Taro Kishi et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

(2012) Robert Howard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacologic Treatment of Apathy in Dementia

(2011) Karen Berman et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

(2010) Lars M. Ittner et al.   NATURE REVIEWS NEUROSCIENCE

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine

(2008) R Schmidt et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY